<SEC-DOCUMENT>0001178913-23-000240.txt : 20230124
<SEC-HEADER>0001178913-23-000240.hdr.sgml : 20230124
<ACCEPTANCE-DATETIME>20230124090018
ACCESSION NUMBER:		0001178913-23-000240
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20230124
FILED AS OF DATE:		20230124
DATE AS OF CHANGE:		20230124

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RedHill Biopharma Ltd.
		CENTRAL INDEX KEY:			0001553846
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35773
		FILM NUMBER:		23545979

	BUSINESS ADDRESS:	
		STREET 1:		21 HA'ARBA'A STREET
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			64739
		BUSINESS PHONE:		972-3-541-3131

	MAIL ADDRESS:	
		STREET 1:		21 HA'ARBA'A STREET
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			64739
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>zk2329054.htm
<DESCRIPTION>6-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using Broadridge PROfile 22.12.1.5105
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-size: 14pt;">
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;"></div>
    <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;"> <br>
    </div>
    <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-size: 14pt;"><font style="font-weight: bold;">&#160;UNITED STATES&#160;</font>&#160;&#160;</div>
    <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
    <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-size: 12pt; font-weight: bold;">Washington, D.C.&#160;20549</div>
    <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',serif; font-size: 14pt; font-weight: bold;">FORM 6-K</div>
    <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">&#160;&#160;</div>
    <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">Report of Foreign Private Issuer</div>
    <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">Pursuant to Rule 13a-16 or 15d-16</div>
    <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">of&#160;the Securities Exchange Act of 1934</div>
    <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">For the month of January 2023<br>
      Commission File No.:001-35773</div>
    <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-size: 18pt; font-weight: bold;">REDHILL BIOPHARMA LTD.</div>
    <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">(Translation of registrant&#8217;s name into English)</div>
    <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">21 Ha'arba'a Street, Tel Aviv, 6473921, Israel</div>
    <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">(Address of principal executive offices)</div>
    <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 28.35pt; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or
      Form 40-F.&#160;&#160;</div>
    <div style="text-align: center; text-indent: 14.2pt; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Form 20-F&#160;<font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9746;</font>&#160;&#160;&#160;&#160;&#160; Form
      40-F&#160;<font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font></div>
    <div style="text-indent: 14.2pt; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 28.35pt; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Indicate by check mark if the Registrant is&#160;submitting&#160;the Form 6-K in paper as permitted by Regulation
      S-T Rule 101(b)(1): ____&#160;</div>
    <div style="text-indent: 28.35pt; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">&#160;</div>
    <div style="text-align: justify; text-indent: 28.35pt; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Indicate by check mark if the Registrant is&#160;submitting&#160;the Form 6-K in paper as permitted by Regulation
      S-T Rule 101(b)(7): ____</div>
    <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">&#160;</div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">This Form 6-K is hereby incorporated by reference into the Company's Registration Statements on Form S-8 filed with the
        Securities and Exchange Commission on May 2, 2013 (Registration No. 333-188286), on October 29, 2015 (Registration No. 333-207654), on July 25, 2017 (Registration No. 333-219441), on May 23, 2018 (Registration No. 333-225122), on July 24, 2019
        (File No. 333-232776), on March 25, 2021 (File No. 333-254692), on May 3, 2021 (File No. 333-255710), on January 11, 2022 (File No. 333-262099) and on June 27, 2022 (File No. 333-265845), and its Registration Statements on Form F-3 filed with the
        Securities and Exchange Commission on March 30, 2021 (File No. 333-254848) and on July 29, 2021 (File No. 333-258259).</div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">RedHill Biopharma&#160;Ltd. (the &#8220;Company&#8221;) announces today
        the adjournment of the Extraordinary General Meeting of Shareholders scheduled for January 24, 2023, due to a lack of required legal quorum.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">The Company has announced that the Extraordinary General
        Meeting of Shareholders will reconvene on January 25, 2023, at 3:00 p.m. Israel time at the Company&#8217;s office.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: David, sans-serif; font-size: 12pt;">&#160;</div>
    </div>
    <div style="text-align: center; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">SIGNATURES</div>
    <div style="text-align: justify; text-indent: 28.35pt; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">Pursuant to the requirements of&#160;the&#160;Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on
      its behalf by the undersigned, thereunto duly authorized.&#160;</div>
    <div style="text-align: justify; margin-left: 220.65pt; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="za663d6e63c1a45eb8cfd3eac29960f1b" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 49.66%; vertical-align: middle;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
          </td>
          <td style="width: 33.91%; vertical-align: middle;" colspan="2">
            <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">REDHILL BIOPHARMA LTD.</div>
          </td>
          <td style="width: 16.42%; vertical-align: bottom;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.66%; vertical-align: middle;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
          </td>
          <td style="width: 33.91%; vertical-align: middle;" colspan="2">
            <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">(the "Registrant")</div>
          </td>
          <td style="width: 16.42%; vertical-align: bottom;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.66%; vertical-align: middle;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
          </td>
          <td style="width: 3.48%; vertical-align: middle;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
          </td>
          <td style="width: 30.44%; vertical-align: middle;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
          </td>
          <td style="width: 16.42%; vertical-align: bottom;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.66%; vertical-align: middle;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">Date: January 24, 2023</div>
          </td>
          <td style="width: 3.48%; vertical-align: middle;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">By:</div>
          </td>
          <td style="width: 30.44%; vertical-align: middle; border-bottom: #000000 2px solid;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;/s/ Dror Ben-Asher&#160;</div>
          </td>
          <td style="width: 16.42%; vertical-align: bottom;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.66%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
          </td>
          <td style="width: 33.91%; vertical-align: middle;" colspan="2">
            <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">Dror Ben-Asher&#160;</div>
          </td>
          <td style="width: 16.42%; vertical-align: bottom;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.66%; vertical-align: top;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
          </td>
          <td style="width: 33.91%; vertical-align: middle;" colspan="2">
            <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">Chief Executive Officer</div>
          </td>
          <td style="width: 16.42%; vertical-align: bottom;">
            <div style="line-height: 1.25; font-family: 'Times New Roman', serif;">&#160;</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
